Skip to content

DR. NATALIE WERY

Active
Private limited companyfounded 2011active for 15 yearsBredabaan 949, 2930 Brasschaat, BelgiumKBO/BCE: BE 0835.013.612

From the official registers: KBO 15 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. NATALIE WERY has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €358,176 and a net result of €126,657. Equity has been growing by about 4.4% per year since 2018. Its solvency ranks better than 41% of 3,024 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 31-03-2011 Normal situation
Activity
General medical practice NACE 86210
Establishment unit
2.197.956.454 2930 Brasschaat, since 31-03-2011
Financial year end
31 December
Peppol
Reachable since 23-09-2025

Board and ownership

Board

Financial position

92 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€170,884
▲ 4.4%
Turnover
≈ €310,000
estimated
Profit
€126,657
▲ 9.9%
Equity
€358,176
▼ 28.0%
Total assets
€739,653
▲ 19.6%
Filed on 11-06-2026, 50 days before the deadlinePDF
Score breakdownlowers riskSector: Human health activities (NACE 86)Size: total assets €739,653Liquidity: current ratio 1.93, cash €540,133Figures for financial year 2025 (filed on 11-06-2026)Show the evidence

Checked score

Score 2025
92 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 39% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 73-27
equity 48.4% of total assets
Liquidity 74-20
short-term debt 51.5% · cash 73.0%
Profitability 90-2
return on assets 17.1%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025highest value 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €30,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.93 (5.1 in 2024), above the usual 1.5. Short-term debt is 51.5% and cash 73% of total assets. However, 51.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 39% of them on solvency, 55% on liquidity, 45% on profitability and 19% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €739,653
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.93, cash €540,133
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 11-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
50 days early
2024
28 days early
2023
3 days early
2022
11 days early
2021
2 days early
2020
9 days early
2019
44 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 8 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €126,657 8 years View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
  • Caution: Equity fell in 2025from €497,703 to €358,176 ▼ 28.0% View

Comparable companies

These companies have the same main activity as DR. NATALIE WERY: general medical practice (NACE 86210). They are comparable in size and age: total assets between €689,000 and €812,000, founded between 2009 and 2011.

CompanyTotal assetsGross margin
DR. NATALIE WERY Brasschaat€739,653€170,884
DOKTER CAROLINE BAETEN Zoersel€737,957€170,441
DOKTER MARK CLAEYS Antwerpen€730,468€163,492
DOKTER HAVA SAHBAZ Antwerpen€802,574€171,648
Dr. Van Mencxel Oud-Turnhout€811,967€169,922
DOKTER H. VAN NERUM Balen€689,236€171,508
DR. A-M RAYMAEKERS Turnhout€761,908€190,509
Full comparison

Documents

Annual accounts at the NBB

All 15 annual accounts

Articles and registers

Key facts about DR. NATALIE WERY

What is the company number of DR. NATALIE WERY?
The company number of DR. NATALIE WERY is 0835.013.612. The VAT number is the same number with BE in front: BE 0835.013.612.
Where is DR. NATALIE WERY based?
The registered office is at Bredabaan 949, 2930 Brasschaat.Company details
What does DR. NATALIE WERY do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR. NATALIE WERY?
The legal form of DR. NATALIE WERY is Private limited company (BV).
When was DR. NATALIE WERY founded?
DR. NATALIE WERY was founded on 31-03-2011.
Is DR. NATALIE WERY still active?
Yes, DR. NATALIE WERY is an active enterprise in the KBO register.
What is the turnover of DR. NATALIE WERY?
The turnover in financial year 2025 is ≈ €310,000. This figure is estimated from the gross margin of €170,884 and 30 comparable companies (NACE 86210). It probably lies between €250,000 and €380,000.Financials
Is DR. NATALIE WERY profitable?
In financial year 2025, DR. NATALIE WERY made a profit of €126,657.
Where can I find the annual accounts of DR. NATALIE WERY?
DR. NATALIE WERY filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of DR. NATALIE WERY due?
DR. NATALIE WERY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.